Share：
Share this content in WeChat
X
[Chinese][PDF]4403
• Review •
Application and progress of advanced MRI techniques in differentiating malignant from benign parotid gland tumors
WEN Baohong  CHENG Jingliang 

Cite this article as: WEN B H, CHENG J L. Application and progress of advanced MRI techniques in differentiating malignant from benign parotid gland tumors[J]. Chin J Magn Reson Imaging, 2023, 14(1): 178-182, 188. DOI:10.12015/issn.1674-8034.2023.01.033.


[Abstract] Parotid gland tumors have a wide variety of pathologic type with similar clinical manifestations, but the treatment strategies and prognosis of them usually are markable difference. Therefore, accurate preoperative diagnosis is of great significance. MRI advanced techniques have more and more applications in differential diagnosis of parotid gland tumors. This article has reviewed application and progress of advanced MRI techniques in differentiating malignant from benign parotid gland tumors, the purpose is to enable clinicians and radiologists to understand the application of advanced MRI techniques in parotid gland tumors.
[Keywords] parotid gland tumors；magnetic resonance imaging；diffusion weighted imaging；diffusion kurtosis imaging；diffusion tensor imaging；arterial spin labeling；magnetic resonance spectroscopy；T2 mapping；magnetic resonance elastography

WEN Baohong   CHENG Jingliang*  

Department of MRI, the First Affiliated Hospital of Zhengzhou University, Zhengzhou 450052, China

Corresponding author: Cheng JL, E-mail: cjr.chjl@vip.163.com

Conflicts of interest   None.

ACKNOWLEDGMENTS Joint Construction Project of Henan Medical Science and Technology Research Program (No. LHGJ20190157).
Received  2022-07-13
Accepted  2022-12-05
DOI: 10.12015/issn.1674-8034.2023.01.033
Cite this article as: WEN B H, CHENG J L. Application and progress of advanced MRI techniques in differentiating malignant from benign parotid gland tumors[J]. Chin J Magn Reson Imaging, 2023, 14(1): 178-182, 188. DOI:10.12015/issn.1674-8034.2023.01.033.

[1]
LOBO R, HAWK J, SRINIVASAN A. A review of salivary gland malignancies: common histologic types, anatomic considerations, and imaging strategies[J]. Neuroimaging Clin N Am, 2018, 28(2): 171-182. DOI: 10.1016/j.nic.2018.01.011.
[2]
WEN B H, CHENG J L, ZHANG H X, et al. The value of high resolution diffusion weighted imaging in differentiating benign and malignant epithelial tumors of parotid gland[J]. Natl Med J China, 2018, 98(17): 1347-1351. DOI: 10.3760/cma.j.issn.0376-2491.2018.17.013.
[3]
JIANG J S, ZHU L N, WU Q, et al. Feasibility study of using simultaneous multi-slice RESOLVE diffusion weighted imaging to assess parotid gland tumors: comparison with conventional RESOLVE diffusion weighted imaging[J/OL]. BMC Med Imaging, 2020, 20(1): 93 [2022-07-01]. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7412638/pdf/12880_2020_Article_492.pdf. DOI: 10.1186/s12880-020-00492-1.
[4]
YOLOGLU Z, AYDIN H, ALP N A, et al. Diffusion weighted magnetic resonance imaging in the diagnosis of parotid masses. Preliminary results[J]. Saudi Med J, 2016, 37(12): 1412-1416. DOI: 10.15537/smj.2016.12.16288.
[5]
MIKASZEWSKI B, MARKIET K, SMUGAŁA A, et al. Diffusion-weighted MRI in the differential diagnosis of parotid malignancies and pleomorphic adenomas: can the accuracy of dynamic MRI be enhanced?[J]. Oral Surg Oral Med Oral Pathol Oral Radiol, 2017, 124(1): 95-103. DOI: 10.1016/j.oooo.2017.03.007.
[6]
ELMOKADEM A H, ABDEL KHALEK A M, ABDEL WAHAB R M, et al. Diagnostic accuracy of multiparametric magnetic resonance imaging for differentiation between parotid neoplasms[J]. J L'association Can Des Radiol, 2019, 70(3): 264-272. DOI: 10.1016/j.carj.2018.10.010.
[7]
ABDEL RAZEK A A K, ELKHAMARY S M, NADA N. Correlation of apparent diffusion coefficient with histopathological parameters of salivary gland cancer[J]. Int J Oral Maxillofac Surg, 2019, 48(8): 995-1000. DOI: 10.1016/j.ijom.2019.03.897.
[8]
ZHANG W, ZUO Z, HUANG X, et al. Value of Diffusion-Weighted Imaging Combined with Susceptibility-Weighted Imaging in Differentiating Benign from Malignant Parotid Gland Lesions[J]. Med Sci Monit, 2018, 24: 4610-4616. DOI: 10.12659/MSM.911185.
[9]
SHI L X, LIU S, ZHENG X W, et al. Application of magnetic resonance diffusion weighted imaging ADC and rADC in differential diagnosis of benign and malignant parotid gland tumors[J]. J Jilin Univ Med Ed, 2020, 46(6): 1309-1314, 1353. DOI: 10.13481/j.1671-587x.20200632.
[10]
HUANG N, XIAO Z B, CHEN Y, et al. Quantitative dynamic contrast-enhanced MRI and readout segmentation of long variable echo-trains diffusion-weighted imaging in differentiating parotid gland tumors[J]. Neuroradiology, 2021, 63(10): 1709-1719. DOI: 10.1007/s00234-021-02758-z.
[11]
SUMI, VAN CAUTEREN M, SUMI T, et al. Salivary gland tumors: use of intravoxel incoherent motion MR imaging for assessment of diffusion and perfusion for the differentiation of benign from malignant tumors[J]. Radiology, 2012, 263(3): 770-777. DOI: 10.1148/radiol.12111248.
[12]
MA G, XU X Q, ZHU L N, et al. Intravoxel incoherent motion magnetic resonance imaging for assessing parotid gland tumors: correlation and comparison with arterial spin labeling imaging[J]. Korean J Radiol, 2021, 22(2): 243-252. DOI: 10.3348/kjr.2020.0290.
[13]
TAKUMI K, FUKUKURA Y, HAKAMADA H, et al. Value of diffusion tensor imaging in differentiating malignant from benign parotid gland tumors[J]. Eur J Radiol, 2017, 95: 249-256. DOI: 10.1016/j.ejrad.2017.08.013.
[14]
KHALEK ABDEL RAZEK A A. Characterization of salivary gland tumours with diffusion tensor imaging[J/OL]. Dentomaxillofac Radiol, 2018, 47(5): 20170343 [2022-07-01]. https://www.birpublications.org/doi/10.1259/dmfr.20170343. DOI: 10.1259/dmfr.20170343.
[15]
QIAN W, XU X Q, ZHU L N, et al. Preliminary study of using diffusion kurtosis imaging for characterizing parotid gland tumors[J]. Acta Radiol, 2019, 60(7): 887-894. DOI: 10.1177/0284185118803784.
[16]
HUANG N, CHEN Y, SHE D J, et al. Diffusion kurtosis imaging and dynamic contrast-enhanced MRI for the differentiation of parotid gland tumors[J]. Eur Radiol, 2022, 32(4): 2748-2759. DOI: 10.1007/s00330-021-08312-y.
[17]
ABDEL RAZEK A A K, MUKHERJI S K. State-of-the-art imaging of salivary gland tumors[J]. Neuroimaging Clin N Am, 2018, 28(2): 303-317. DOI: 10.1016/j.nic.2018.01.009.
[18]
LAM P D, KURIBAYASHI A, IMAIZUMI A, et al. Differentiating benign and malignant salivary gland tumours: diagnostic criteria and the accuracy of dynamic contrast-enhanced MRI with high temporal resolution[J/OL]. Br J Radiol, 2015, 88(1049): 20140685 [2022-07-01]. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4628473/pdf/bjr.20140685.pdf. DOI: 10.1259/bjr.20140685.
[19]
YABUUCHI H, FUKUYA T, TAJIMA T, et al. Salivary gland tumors: diagnostic value of gadolinium-enhanced dynamic MR imaging with histopathologic correlation[J]. Radiology, 2003, 226(2): 345-354. DOI: 10.1148/radiol.2262011486.
[20]
ZHENG N, LI R, LIU W, et al. The diagnostic value of combining conventional, diffusion-weighted imaging and dynamic contrast-enhanced MRI for salivary gland tumors[J/OL]. Br J Radiol, 2018, 91(1089): 20170707 [2022-07-01]. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6223171/pdf/bjr.20170707.pdf. DOI: 10.1259/bjr.20170707.
[21]
MIKASZEWSKI B, MARKIET K, SMUGAŁA A, et al. Parotid malignancies are not homogenous in terms of their presentation on dynamic MRI-a preliminary report[J]. Acta Otolaryngol, 2017, 137(2): 215-220. DOI: 10.1080/00016489.2016.1225317.
[22]
XU Z F, ZHENG S Y, PAN A Z, et al. A multiparametric analysis based on DCE-MRI to improve the accuracy of parotid tumor discrimination[J]. Eur J Nucl Med Mol Imaging, 2019, 46(11): 2228-2234. DOI: 10.1007/s00259-019-04447-9.
[23]
RAZEK A A K A, SAMIR S, ASHMALLA G A. Characterization of parotid tumors with dynamic susceptibility contrast perfusion-weighted magnetic resonance imaging and diffusion-weighted MR imaging[J]. J Comput Assist Tomogr, 2017, 41(1): 131-136. DOI: 10.1097/RCT.0000000000000486.
[24]
HU H, CHEN L, ZHU L N, et al. Influence of post-label delay time on the performance of 3D pseudo-continuous arterial spin labeling magnetic resonance imaging in the characterization of parotid gland tumors[J]. Eur Radiol, 2022, 32(2): 1087-1094. DOI: 10.1007/s00330-021-08220-1.
[25]
RAZEK A A K A. Multi-parametric MR imaging using pseudo-continuous arterial-spin labeling and diffusion-weighted MR imaging in differentiating subtypes of parotid tumors[J]. Magn Reson Imaging, 2019, 63: 55-59. DOI: 10.1016/j.mri.2019.08.005.
[26]
YAMAMOTO T, KIMURA H, HAYASHI K, et al. Pseudo-continuous arterial spin labeling MR images in Warthin tumors and pleomorphic adenomas of the parotid gland: qualitative and quantitative analyses and their correlation with histopathologic and DWI and dynamic contrast enhanced MRI findings[J]. Neuroradiology, 2018, 60(8): 803-812. DOI: 10.1007/s00234-018-2046-9.
[27]
KHAMIS M E M, AHMED A F, ISMAIL E I, et al. The diagnostic efficacy of apparent diffusion coefficient value and Choline/Creatine ratio in differentiation between parotid gland tumors[J]. Egypt J Radiol Nucl Med, 2018, 49(2): 358-367. DOI: 10.1016/j.ejrnm.2018.02.004.
[28]
BÖKER S M, ADAMS L C, BENDER Y Y, et al. Differentiation of predominantly osteoblastic and osteolytic spine metastases by using susceptibility-weighted MRI[J]. Radiology, 2019, 290(1): 146-154. DOI: 10.1148/radiol.2018172727.
[29]
ZHANG S, CHIANG G C, KNAPP J M, et al. Grading meningiomas utilizing multiparametric MRI with inclusion of susceptibility weighted imaging and quantitative susceptibility mapping[J]. J De Neuroradiol, 2020, 47(4): 272-277. DOI: 10.1016/j.neurad.2019.05.002.
[30]
JIANG J S, ZHU L N, CHEN W, et al. Added value of susceptibility-weighted imaging to diffusion-weighted imaging in the characterization of parotid gland tumors[J]. Eur Arch Otorhinolaryngol, 2020, 277(10): 2839-2846. DOI: 10.1007/s00405-020-05985-x.
[31]
YUAN J, CHEN S Z, KING A D, et al. Amide proton transfer-weighted imaging of the head and neck at 3 T: a feasibility study on healthy human subjects and patients with head and neck cancer[J]. NMR Biomed, 2014, 27(10): 1239-1247. DOI: 10.1002/nbm.3184.
[32]
BAE Y J, CHOI B S, JEONG W J, et al. Amide Proton Transfer-weighted MRI in the Diagnosis of Major Salivary Gland Tumors[J/OL]. Sci Rep, 2019, 9(1): 8349 [2022-07-01]. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6554276/pdf/41598_2019_Article_44820.pdf. DOI: 10.1038/s41598-019-44820-0.
[33]
CHEN Y, WANG X Q, SU T, et al. Feasibility evaluation of amide proton transfer-weighted imaging in the parotid glands: a strategy to recognize artifacts and measure APT value[J]. Quant Imaging Med Surg, 2021, 11(6): 2279-2291. DOI: 10.21037/qims-20-675.
[34]
WU Q, ZHU L N, JIANG J S, et al. Characterization of parotid gland tumors using T2 mapping imaging: initial findings[J]. Acta Radiol, 2020, 61(5): 629-635. DOI: 10.1177/0284185119875646.
[35]
WEN B H, ZHU J, ZHANG Z X, et al. T2 mapping and readout segmentation of long variable echo-train diffusion-weighted imaging for the differentiation of parotid gland tumors[J/OL]. Eur J Radiol, 2022, 151: 110265 [2022-07-01]. DOI: 10.1016/j.ejrad.2022.110265.
[36]
ELSHOLTZ F H J, REITER R, MARTICORENA GARCIA S R, et al. Multifrequency magnetic resonance elastography-based tomoelastography of the parotid glands-feasibility and reference values[J]. Dentomaxillofac Radio, 2022, 51(1): 20210337 [2022-07-01]. https://www.birpublications.org/doi/epub/10.1259/dmfr.20210337. DOI: 10.1259/dmfr.20210337.

PREV Research progress in imaging of carotid calcified plaque
NEXT Progress and prospects of ultrashort echo time magnetic resonance imaging for pulmonary nodules
  


LINK


Tel & Fax: +8610-67113815    E-mail: editor@cjmri.cn